Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma: A Prospective Clinical Trial

NCT06171321 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT06171321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06171321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma: A Prospective Clinical Trial
Lead sponsor
Shanghai East Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2023
Completion date
April 1, 2026
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer